Center for Biophotonic Technology and Artificial Intelligence (CeBAI) Symposium

Biophotonics empowered by Artificial Intelligence (AI) is a novel approach for the analysis of biological systems. The method is particularly attractive for bioanalytics because it is nondestructive, highly sensitive, and suitable for a wide variety of samples, including cells, tissues, and fluids. Advances in instrumentation, including portable spectrometers, have made it possible to use these techniques for real-time analysis and in situ measurements. This novel approach is further empowered by improved AI methods for data interpretation. This symposium highlights cutting-edge research and challenges in the application of Biophotonics combined with AI to bioanalysis with a specific focus on biomedical science.
The South-Central region of the US, including internationally recognized research programs at the University of Texas at San Antonio (UTSA) and the University of Houston (UH), is a vibrant hub in the rapidly developing field of medical applications of biophotonics and AI. Prof. Kelly Nash, academic researcher and invertor from UTSA, will speak on the development of optical laser catheter for intracorporeal diagnostic and treatment based photoacoustic spectroscopy. Prof. Kirill Larin, reasercher and inteprenuer from UH, will describe a novel techniques and methods for tissue structural and functional imaging such as optical coherence tomography and elastography.
CeBAI (https://www.albany.edu/biophotonic-technology-artificial-intelligence) is a recently inaugurated joint center between the Leibniz Institute of Photonic Technology, Jena, Germany and the University at Albany, SUNY, USA. The main goal of the Center is to utilize expertise and experience of the two institutions in translational research and development and to bring modern spectroscopy empowered by the AI to practice. Drs. Popp and Lednev will briefly introduce the goal of a new Center and discuss the novel developments for the field of AI-Biophotonics for infectious and neurodegenerative diseases.